| scholarly article | Q13442814 |
| P50 | author | Rosamonde Elizabeth Banks | Q37631551 |
| P2093 | author name string | D Thompson | |
| J T Whicher | |||
| P J Selby | |||
| M Storr | |||
| M A Forbes | |||
| J Higginson | |||
| T J Perren | |||
| J Raynes | |||
| J M Illingworth | |||
| P2860 | cites work | Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia | Q34240849 |
| Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. | Q36350763 | ||
| Monokines regulate glycosylation of acute-phase proteins | Q36353706 | ||
| Defective inflammatory response in interleukin 6-deficient mice | Q36363772 | ||
| Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes | Q36965573 | ||
| Purification of serum amyloid A and other high density apolipoproteins by hydrophobic interaction chromatography | Q39387514 | ||
| Counterregulatory effects of interferon-gamma and endotoxin on expression of the human C4 genes | Q40346733 | ||
| Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study | Q40696313 | ||
| Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies | Q40721212 | ||
| The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein | Q40738906 | ||
| Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial | Q40754340 | ||
| Post-transcriptional control of negative acute phase genes by transforming growth factor beta | Q40822282 | ||
| Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression | Q40919631 | ||
| A phase I trial of intravenous interleukin-6 in patients with advanced cancer. | Q41035933 | ||
| Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. | Q41520431 | ||
| Insulin modulation of acute-phase protein production in a human hepatoma cell line | Q41658623 | ||
| Hormonal regulation of complement biosynthesis in human cell lines--II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line. | Q41745659 | ||
| Automated measurement of plasma viscosity by capillary viscometer | Q41980181 | ||
| Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency | Q42058341 | ||
| Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. | Q42488526 | ||
| Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone | Q43587850 | ||
| A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro | Q44572783 | ||
| High levels of "complexed" interleukin-6 in human blood | Q44837307 | ||
| Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells. | Q45039889 | ||
| Response of interleukin‐6‐deficient mice to tumor necrosis factor‐induced metabolic changes and lethality | Q49167959 | ||
| Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate--the marmoset | Q50115675 | ||
| Sequential changes of plasma proteins after surgical trauma | Q50166145 | ||
| Standardisation of the quantitation of serum amyloid A protein (SAA) in human serum. | Q50913327 | ||
| Impaired immune and acute-phase responses in interleukin-6-deficient mice. | Q52514391 | ||
| Modified nuclear processing of alpha 1-acid glycoprotein RNA during inflammation | Q58479995 | ||
| Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6 | Q58681737 | ||
| Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells | Q67493801 | ||
| Functional evaluation of tumor-infiltrating mononuclear cells. Detection of endogenous interferon-γ and tumor necrosis factor-α in human colorectal adenocarcinomas | Q67700808 | ||
| Serum levels of cytokines in chronic liver diseases | Q68169595 | ||
| Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines | Q69047745 | ||
| Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis | Q70176986 | ||
| Regulation of synthesis of complement proteins in HEp2 cells | Q70781051 | ||
| The acute phase response | Q71618259 | ||
| Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 | Q72690586 | ||
| Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity | Q72769183 | ||
| In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons | Q72775835 | ||
| Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis | Q72783362 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 217-223 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | The acute phase protein response in patients receiving subcutaneous IL-6 | |
| P478 | volume | 102 |
| Q42577309 | A case of neutrophilia related to a cytokine-producing relapsed squamous cell carcinoma of the uterine cervix arising from the rectovaginal septum |
| Q35674454 | A novel pathway to the manifestations of metabolic syndrome |
| Q33597715 | Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer |
| Q58095171 | CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial |
| Q82028773 | Chapter 17 Cytokines and pain |
| Q45249828 | Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition |
| Q46363960 | Combined effect of C-reactive protein gene SNP +2147 A/G and interleukin-6 receptor gene SNP rs2229238 C/T on anthropometric characteristics among school children in Taiwan |
| Q41695652 | Cytokines and the liver |
| Q98776098 | Decreased prealbumin level is associated with increased risk for mortality in elderly hospitalized patients with COVID-19 |
| Q47276539 | Discrepancy of interleukin-6 levels between end-stage renal disease patients and patients with acute-phase response with increased lipoprotein(a) concentrations |
| Q46545391 | Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder. |
| Q46689229 | Evidence for the association between abdominal fat and cardiovascular risk factors in overweight and obese African American women |
| Q38336406 | From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis |
| Q74000020 | Higher levels of inflammation in obese children |
| Q34331335 | Human alpha-1-glycoprotein and its interactions with drugs |
| Q37949664 | IL-6/IL-6 receptor system and its role in physiological and pathological conditions |
| Q47870972 | Impact of acute malaria on plasma concentrations of transferrin receptors |
| Q44046211 | Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy. |
| Q34463786 | Is obesity an inflammatory condition? |
| Q31050788 | Laboratory environment and bio-medical experience: the impact of administration technique on the quality of immune-behavior data results in stress experience |
| Q42368268 | Lean Body Mass Harbors Sensing Mechanisms that Allow Safeguarding of Methionine Homeostasis |
| Q45217380 | Markers of inflammation in type 1 diabetic patients |
| Q58314403 | Markers of the Acute Phase Response in Cardiovascular Disease: An Update |
| Q37640922 | Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection |
| Q36202135 | Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies |
| Q33332598 | Pharmacologic treatment options in patients with thrombocytopenia |
| Q41560071 | Pharmacological approaches and strategies for therapeutic modulation of fibrinogen |
| Q57571627 | Phase I study of interleukin-6 in children with solid tumours in relapse |
| Q44317813 | Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. |
| Q64987958 | Plasma Transthyretin as A Biomarker of Sarcopenia in Elderly Subjects. |
| Q26786816 | Plasma Transthyretin as a Biomarker of Lean Body Mass and Catabolic States |
| Q33183469 | Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b |
| Q60441351 | Role of visceral proteins in detecting malnutrition in the elderly |
| Q50571518 | Serum-haptoglobin concentration in Danish slaughter pigs of different health status. |
| Q53934175 | Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. |
| Q37213846 | Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum |
| Q58764738 | The Retinol Circulating Complex Releases Hormonal Ligands During Acute Stress Disorders |
| Q42234561 | The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity. |
| Q28252425 | The dark side of C5a in sepsis |
| Q45189804 | The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile mice. |
| Q22252194 | The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen |
| Q90080201 | Type I interferons and endoplasmic reticulum stress in health and disease |
Search more.